Moderna’s personalised mRNA cancer vaccine met key goals in a Phase 3 melanoma trial, triggering a sharp stock rally and boosting hopes for mRNA-based cancer treatments beyond COVID-19.
Standard Chartered is increasing its focus on hedge funds as wealth management clients seek to diversify portfolios and navigate heightened market volatility. The bank is emphasising strategies such as equity market neutral and multi-strategy funds as alternative investments gain traction among affluent investors in Asia.
PFC and REC shares fell on Thursday after Morgan Stanley downgraded both stocks to Equal-Weight and cut their target prices. The brokerage flagged slower loan growth and lowered earnings estimates for FY28 and FY29. The downgrade comes ahead of the proposed PFC-REC merger, with both stocks already under pressure.
Coforge shares climbed on Thursdat after the IT services company launched a dedicated Private Equity business unit to help funds drive operational transformation and value creation across portfolio companies. The new vertical will leverage Coforge’s acquisition integration expertise and AI capabilities to support portfolio optimisation, EBITDA growth and technology-led transformation.
Titagarh Rail Systems shares rose after Indian Railways approved the company as a vendor for supplying three-phase asynchronous traction motors for locomotives. The approval allows Titagarh to supply up to 1,200 traction motors annually, boosting its prospects in the railway equipment segment.
The regulator flagged three sharp Sensex spikes, including a 362-point jump in two seconds and a 405-point surge in 28 seconds, as the index’s CAS closing price moved to around 78,080 from a 3:15 pm reference of 77,829.60.
China and Hong Kong stocks rebounded on Thursday, led by healthcare and technology shares, after a sharp selloff in the previous session. Fresh share buyback announcements also supported sentiment, while gains in South Korea and Japan helped broader Asian markets recover. Investors remained cautious amid heightened volatility.
Jefferies has initiated coverage on Turtlemint Fintech Solutions with a Buy rating and a target price of Rs 190, implying 37% upside. The brokerage expects revenue to grow at a 38% CAGR over three years, driven by higher premiums and take-rates.
Sugar stocks rallied up to 8% after the government tightened inventory limits for dealers amid record-high sugar prices. Bajaj Hindusthan Sugar led gains, while Balrampur Chini and other stocks also advanced. Concerns over domestic and Brazilian supply, rising festive-season demand and a possible cut in import duties have further supported prices.
Jefferies has raised its target price for Emmvee Photovoltaic Power to Rs 440 from Rs 400, while retaining its Buy rating, implying around 31% upside. The brokerage is bullish on the company’s strong solar PV value-chain presence, healthy order book and expansion plans
Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.